In cancer cell lines, overexpression of wild‐type (WT) PRMT1, but not catalytically inactive mutants (E133Q and E142Q), enhanced vimentin R64 aDMA in both HeLa and A549 cells stably expressing Flag‐vimentin (Figure 5E,F). This evidence concerns the gene VIM and cancer.